Atnas Pharma

Atnas Pharma is a specialty pharmaceutical company that operates as a key entity within the Pharmanovia group, focusing on the acquisition and revitalization of niche legacy brands from global pharmaceutical leaders. The company specializes in lifecycle management, ensuring that established medicines remain available to patients while optimizing their commercial potential through geographic expansion and value-added improvements. Their diverse portfolio covers critical therapeutic areas such as oncology, endocrinology, neurology, and cardiovascular disease. Headquartered in the United Kingdom, Atnas Pharma utilizes a robust global distribution network to serve over 140 markets worldwide. The company is known for its strategic partnerships with major firms like Roche and GSK to manage divested product portfolios.